drugs as treatment for, xx–xxi
effects of, 28
environmental influences role in, 428–31
Freud on, 144
genetic influences role in, 428–31, 460–62
hopelessness and, 387, 405–6
identifying silent assumptions downward-arrow method, 264–88
medical science’s approach to, 403–4
mild chronic, 24
National Institute of Mental Health on, 16–17
negative self-evaluation, 54–56
negative thinking and, 28–29, 47–48, 58–59
physical symptoms of, 25–26, 432
prevalency of, 9
as product of mental slippage, 13
psychotherapy for, xxi–xxii
realistic, 233
relapses, xxvii–xxviii, 492
sadness and, 231–32
schizophrenia and, 57–58
self-dislike and, 53
sexual drive and, 58
suicide and, 383
willpower and, 81
see also antidepressant drug therapy; suicidal individual
Depression: Causes and Treatment (Beck), 53, 383n
Depression: Clinical, Experimental & Theoretical Aspects (Beck), 53n
Descartes, René, 455
desipramine (Norpramin, Pertofrane), 518
side effects, 531
Desyrel, 451–52, 484, 521, 599
doses, 600
drug interactions, 603–5
side effects, 600–3, 601
Diagnostic and Statistical Manual (DSM), xxvi
disapproval, 301–9
fear of, 290–92
self-respect and, 301–9
disarming critics, 137–42
disarming technique, 117–19
disattribution, 225–26
disqualifying the positive, 34–36, 42
divalproex sodium (Depakote), 522
do-nothingism, 81–130
coercion, 92
examples of, 83
fear of disapproval or criticism, 92
fear of failure, 90–91
fear of success, 91–92
guilt, 93
hopelessness, 82
jumping to conclusions, 89
low frustration tolerance, 92–93
overwhelming oneself, 89
perfectionism, 90
resentment, 92
self-activation methods, 94–130
self-blame, 93
self-labeling, 89–90
undervaluing the rewards, 90
doxepin (Adapin, Sinequan), 484, 518
side effects, 531
DSM. See Diagnostic and Statistical Manual
Dunton, William G., xx
Dyer, Wayne, 162–63
Dysfunctional Attitude Scale (DAS), 270–89, 296
interpreting your score, 285–89
scoring, 281–84
Dysfunctional Thoughts, Daily Record of, 65–67, 66, 100–4, 101–3, 106–7, 170, 208
dysthymic disorder, 24
eating disorders, cognitive therapy for, xxiii
Effexor,450, 521, 611–12
doses, 612–14
drug interactions, 614–15
side effects, 608, 614
Einstein, Albert, 160, 163
Elavil, 448–49, 518
side effects, 499–500, 530
Eldepryl, 444
side effects, 573
Ellis, Albert, 10n, 116
emotional reasoning, 38, 42, 79
empathy, 135–37, 207
accurate, 184–85
empathy method, 304–6
Endep, side effects, 530
endorsing yourself, 109–10
enlightened manipulation, 177–80
entitlement, DAS test score and, 287–88
environmental influences, role in depression, 428–31
Eskalith, 522
facts, feelings and, 47–48
failure, fear of, 90–91
fairness, relativity of, 160–62
fear of criticism, 92
overcoming, 131–44
fear of disapproval, 92, 290–92
fear of failure, 90–91
fear of success, 91–92
feedback, 141–44
Feeling Good (Burns), xxix–xxx
Feeling Good Handbook (Burns), xxix
feelings, facts and, 47–48
Floyd, Mark, xxviii
fluoxetine (Prozac), 449–50, 484, 520
side effects, 503–4
fluvoxamine (Luvox), 484, 520
fortune teller error, 37, 42
Freud, Sigmund, 55–56, 144, 153, 198
frustration, 195–96
gabapentin (Neurontin), 522, 651–53
doses, 653–54
drug interactions, 655–58
side effects, 654–55, 656–57
Gabitril, 651–52
Garfield, Sol L., 459
generic drugs, 516
genetic influences, role in depression, 428–31, 460–62
The Gerontologist, xxiii
Goldstein, Mark K., 178
gratification, 316–18
“grieving” method, 308–9
guilt, 93–94, 198–228
cycle of, 203–4
defeating, 207–28
distortions causing, 199
inappropriate “should” statements, 201–3
irresponsibility of, 204–7
thoughts leading to, 198–99
habit management, 122
Hamilton Rating Scale for Depression (HRSD), xxiv–xxvii
happiness, success and, 329–30
healthy sadness, 254–55
helplessness, 88
coping with, 419–22
heroin, 330
Hitler, Adolf, 292, 331
hopelessness, 88, 472–73
depression and, 387–88, 404–5
suicidal individuals and, 386–87, 400, 404–5
Horney, Karen, 10n
hostility, coping with, 411–16, 415
HRSD. See Hamilton Rating Scale for Depression
human worth scale, 235
hyperpyretic crisis, 575–77
how to avoid, 577–79
medications and drugs to avoid concerning, 583–99
hypertensive crisis, 575–77
foods to avoid concerning, 579–82
how to avoid, 577–79
medications and drugs to avoid concerning, 583–98
illusions, 31–32
imaging techniques, 169–72
imipramine (Tofranil), 13, 448–49, 519
vs. Prozac, 516
side effects, 531
imipramine pamoate (Tofranil PM), 519
independence, 296–309
cost-benefit analysis, 296–98
disapproval and, 301–8
need for love, 312–13, 314, 324–26
rejection and, 301–9
self-respect blueprint, 298–300
verbal techniques, 300–1
Inderal, 502
ingratitude, coping with, 416–19, 418
internal dialogue, 30
internalized anger, 153
iproniazid, 443–44
irrational statements, 159–60
Irritability Quotient, 149
calculating, 152–53
isocarboxazid (Marplan), 572
Jamison, Christine, xxiii, xxviii
Jews, 292
job, loss of, 240–50
Journal of Consulting and Clinical Psychology, xxiii
jumping to conclusions, 36, 42, 89
Kaiser facility, 22n
labeling, 39–40, 43, 157
Lamictal, 522, 658–59
lamotrigine (Lamictal), 522, 658–59
Lazarus, Arnold, 10n
learning to expect craziness, 176–77
Lethargy Cycle, 86, 87
life, loss of, 233–36
malignant attitudes toward, 234
limb, loss of, 237
–39
distorted attitudes toward, 237–38
lithium (Eskalith), 26, 522, 617–20
blood testing, 621–22
doses, 620–21
drug interactions, 629–34, 630–31
medical tests prior to treatment with, 621–22
side effects, 502, 623–29
loneliness, being alone and, 313–18
loss of job, 240–50
loss of life, 233–36
malignant attitude toward, 233–34
loss of limb, 237–40
distorted attitudes toward, 234
loss of a loved one, 251–54
love, 286–87
DAS test score and, 285
need for, 311–26
love junkie, analysis of the presumed “advantages” of being a, 314–15
loved one, loss of, 251–54
low frustration tolerance, 92–93
Ludiomil, 519
side effects, 536
Luvox, 484, 520
magnification, 37–38, 42, 158
maladaptive anger, 164
mania, symptoms of, 26–27
manipulative rejection, 303–4
Manson, Charles, 292
MAO, 438
MAO inhibitors, 444–48, 514, 520, 564–67
doses, 567–69
foods to avoid when taking, 579–82, 580–81
medications and drugs to avoid when taking, 583–98, 584–90
names, doses, and costs, 520
side effects, 569–75, 572–73
toxic reactions caused by, 575–79
maprotiline (Ludiomil), 519
side effects, 536
Marplan, 572
Marshall, E., 18n
medical science approaches to depressive illness, 403–4
mental disorders, major, symptoms of, 26
mental filter, 34, 42
mid-life crisis, 400–3
mind reading, 36, 42, 143
minimization, 38, 42
Minnet, Ann M., xxix
minor tranquilizers (benzodiazepines), 671–73
mirtazapine (Remeron), 452, 521, 615
doses, 615–16
drug interactions, 617
side effects, 609, 616–17
mislabeling, 38–39, 43
monoamine oxidase. See MAO
monoamine oxidase inhibitors. See MAO inhibitors
Monroe, Marilyn, 57
Mood Clinic (University of Pennsylvania), 10, 10n, 13, 412,413
mood-control techniques of cognitive therapy, 11
mood stabilizers, 515
carbamazepine (Tegretol), 640–51
gabapentin (Neurontin), 651–58
lithium (Eskalith), 617–34
names, doses, and costs, 522
side effects, 624–25
tiagabine (Gabitril), 651–52
valproic acid, 634–40
vigabatrin (Sabril), 651–52
mood swings, 263, 385, 399
Moorey, Stirling, 223
Moorey moaner method, 223–24
motivation
action and, 125–27
coercion and, 92, 116–17
motivational paralysis, 86
“Mourning and Melancholia” (Freud), 56
Murphy, George E., 459
musterbation, 39, 116
Nardil, 444, 520
side effects, 572
National Institute of Mental Health, 17–18
need for love, 311–26
attitude modification, 320–26
dependency and, 311, 312–15, 324–25
independence and, 313–14, 324–25
Pleasure-Predicting Sheet, 318–24
nefazodone (Serzone), 451–52, 521, 599
doses, 600
drug interactions, 603–5
side effects, 600–3, 601
negative self-evaluation, 53–54
negative thinking, 244
depression and, 28–29, 48–49, 57–58
negotiation, 142–44, 182–84
neuroleptics, 675–76
Neurontin, 522, 651–53
doses, 653–54
drug interactions, 655–58
side effects, 654–55, 656–57
nihilism, 394
nondirective therapy, 60
Norpramin, 518
side effects, 531
nortriptyline (Aventyl), 519
side effects, 532
Novaco, Raymond W., 150n
obsessive-compulsive disorder (OCD), 484
OCD. See obsessive-compulsive disorder
Oedipal incestuous fantasies, 198
omnipotence, DAS test score and, 288
operationalization, 339
original sin, 198
overcoming perfectionism, 352–80
absurdity of all-or-nothing thinking, 372
advantages and disadvantages, 354
Antiperfectionism Sheet, 356–58
benefiting from failure, 361–66
developing process orientation, 367–69
focusing on happy memories, 378–79
focusing on positive side, 372
learning to make mistakes, 370–71
learning from mistakes, 380
lowering one’s standards, 354, 379
personal disclosure, 374–78
as a realistic goal, 358
Response-Prevention Form, 361–62
the role of fear, 360
setting time limits on one’s activities, 370
overgeneralization, 33–34, 42
overwhelming yourself, 89
Parnate, 444, 484
side effects, 573
paroxetine (Paxil), 520
passive-aggressive type, 85
passive death wish, 386
Paxil, 520
PDR. See Physician’s Desk Reference
perfectionism, 90
DAS test score and, 285
overcoming, 352–80
personal inadequacy, 53–55
personality disorders, cognitive therapy for, xxii
personalization, 40–41, 200
Pertofrane, side effects, 531
PET scanning. See positron emission tomography
phenelzine (Nardil), 444, 520
side effects, 572
physical handicaps, 237–40
Physician’s Desk Reference (PDR), 512
Pleasure-Predicting Sheet, 104–7, 105, 318–22, 579, 349, 350
polypharmacy, 476–77, 677–81
positive, the, disqualifying, 34–35, 42
positron emission tomography (PET scanning), xxii
pregnant women, antidepressants and, 480
Prinze, Freddie, 57
procrastination, 38, 83–84, 86
productive anger, 163–64
productivity scale, 235
propranolol (Inderal), 502
protriptyline (Vivactil), 519
side effects, 532
Prozac, 427, 449–50, 484, 501, 520
vs. imipramine, 516
side effects, 503–4
psychotherapy, 12, 403
vs. biological treatments, 456–73
myths concerning, 468–73
studies concerning, 457–60
“Psychotherapy vs. Medication for Depression,” xx
“Psychotherapy Works, but for Whom?” (Marshall), 18n
rational responses (self-defense), 244
realistic depressions, 232–33
reasoning, emotional, 38, 42, 79
reducing anger, methods of
accurate empathy, 184–91
anger hierarchy, 191–92
cognitive rehearsal, 191–94
cooling hot thoughts, 167–69
develop the desire, 165–67
enlightened manipulation, 177–80
imaging techniques, 169–72
learn to expect craziness, 176–77
negotiating strategies, 182–84
putting it all together, 191–94<
br />
rewrite the rules, 172–74
“should” reduction, 180
thought stoppage, 172
rejection, 301–7
recovering from, 308–9
relativity of fairness, 160–62
Remeron, 452, 521, 615
doses, 615–16
drug interactions, 617
side effects, 609, 616–17
remorse, 199
resentment, 92
response prevention, 360
Response-Prevention Form, 361
revenge, developing desire for, 165–67
rewriting the rules, 172–74
Rothko, Mark, 57.
Sabril, 651–52
sadness
depression and, 231–32
without suffering, 254–55
Santrock, John W., xxix
Schatzberg, Alan F., 574, 598, 627, 640, 643, 658, 662, 663
schizophrenia, depression and, 57
Schwartz, Jeffrey M., xxi–xxii, 457
Science, 18n
Scogin, Forest, xxiii, xxiv, xxviii
sedatives, 673–75
selective serotonin reuptake inhibitors. See SSR inhibitors
selegiline (Eldepryl), 444
side effects, 573
Self-Activation Methods, synopsis of, 128–30
self-approval, 309–10
self-blame, 93
self-criticism, 62–67, 68, 76–77, 134, 243, 261
triple-column technique concerning, 63
self-defeating behavior, 84–85
self-defense, 62–67, 68, 76–77, 134, 141, 244, 248–49
self-dislike, 53
self-esteem, 235, 261–62
accomplishments and, 327–40
the achievement trap, 345–51
boosting, 53–80
four paths to, 341–45
Pleasure-Predicting Sheet, 349–50
specific methods for, 62–80
self-evaluation, negative, 55–56
self-labeling, 89–90
self-respect, 296–309
blueprint for, 298–300
cost-benefit analysis, 296–98, 297–98
disapproval and, 301–9
rejection and, 301–9
verbal techniques, 300–1
sense of worthlessness, overcoming, 59–61
serotonin, 440–41
serotonin antagonists, 514, 599
doses, 599
drug interactions, 603–5
names, doses, and costs, 521
side effects, 601
sertraline (Zoloft), 520
Serzone, 451–52, 521, 599
doses, 600
drug interactions, 603–5
side effects, 600–3, 601
sexual drive, depression and, 58–59
“should” statements, 39, 42, 175, 181, 208–11
side effects, antidepressant drugs, 492–98
checklist, 494–96
preventing or minimizing, 501–5
reasons for, 498–501
silent assumptions, 262–63
cost-benefit method for evaluating, 297–98
downward-arrow technique, 264–70
Dysfunctional Attitude Scale, 270–89, 296
vertical-arrow technique, 263–70
Simons, Anne D., 459
Sinequan, 484, 518
side effects, 531
Feeling Good: The New Mood Therapy Page 60